I am a pharmacologist with research interests in precision dosing, solid organ transplantation and oncology. My interest in this work stems from taking care of transplant patients in the clinic and seeing how every patient had a different response to the immunosuppressive drugs. Some experienced rejection despite having therapeutic drug levels, while others had side effects that kept them from enjoying life.
My goal is to develop precision dosing tools that can be more quickly and easily translated into practice using implementation science, with a focus on incorporating the patient and family perspective. My research aims to identify and incorporate sources of variability in drug exposure and response to provide individualized drug doses that improve outcomes by maximizing efficacy while reducing toxicity.
Some of my accomplishments include the development of an analytical assay and clinical tools to improve therapeutic drug monitoring in solid organ transplantation by allowing patients to collect the needed blood samples at home. This includes using a lancet device to obtain small, dried blood samples from their arm and mobile technology to improve adherence and accuracy. Providing multiple samples in the same day using this technique can improve the accuracy with which we dose immunosuppressive drugs.
I have been a researcher for over 10 years and began working at Cincinnati Children's in 2024. I was honored to receive the New Investigator Award from the American College of Clinical Pharmacy Transplant Practice and Research Network.
PharmD: University of Michigan, Ann Arbor, MI, 2013.
MS: University of Cincinnati, Cincinnati, OH, 2018.
PhD: University of Michigan, Ann Arbor, MI, 2024.
Residency: Ohio State Wexner Medical Center, Columbus, OH 2015.
Residency: Johns Hopkins Hospital, Baltimore, MD, 2014.
Fellowship: University of Cincinnati, Cincinnati, OH 2017.
Precision dosing; home-based therapeutic drug monitoring; pediatric pharmacology; clinical pharmacology
Clinical Pharmacology
Clinical validation of two volumetric absorptive microsampling devices to support home-based therapeutic drug monitoring of immunosuppression. British Journal of Clinical Pharmacology. 2024; 90:2897-2909.
Electronic health record-enabled routine assessment of medication adherence after solid organ transplantation: the time is now. American Journal of Transplantation. 2024; 24:711-715.
A Comprehensive Mixed-Method Approach to Characterize the Source of Diurnal Tacrolimus Exposure Variability in Children: Systematic Review, Meta-analysis, and Application to an Existing Data Set. The Journal of Clinical Pharmacology. 2024; 64:334-344.
Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill children. Bioanalysis. 2024; 16:19-31.
Volumetric Absorptive Microsampling to Enhance the Therapeutic Drug Monitoring of Tacrolimus and Mycophenolic Acid: A Systematic Review and Critical Assessment. Therapeutic Drug Monitoring. 2023; 45:463-478.
Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppression. Bioanalysis. 2022; 14:1141-1152.
The use of non-transplant biologics in solid organ transplant recipients: A practical review for the frontline clinician. Clinical Transplantation. 2022; 36:e14743.
Evaluation of the Relationship between Medication Adherence and Tacrolimus Coefficient of Variation. Progress in Transplantation: the journal for procurement and clinical transplant professionals. 2022; 32:15269248221087440.
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2021; 41:649-657.
Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2021; 41:103-118.